Childhood Regulatory Problems Tied to Behavioral Problems in Young Adults

THURSDAY, Jan. 19, 2023 (HealthDay News) -- There are long-lasting associations between multiple or persistent regulatory problems (RPs) in childhood and behavioral problems that extend into adulthood, according to a study published online Jan. 5 in the Journal of Child Psychology and Psychiatry.
Dieter Wolke, Ph.D., from University of Warwick in the United Kingdom, and colleagues assessed whether RPs (excessive crying, sleeping, or feeding difficulties) that co-occur (i.e., multiple) or are persistent are associated with cognitive and behavioral problems in adulthood. The analysis included 759 children assessed for RPs at 5, 20, and 56 months, with follow-up to young adulthood.
The researchers found that adults who had early multiple or persistent RPs (151 individuals) reported more internalizing, externalizing, and total behavioral problems. Specifically, as adults, participants reported more depressive, somatic, avoidant personality, and antisocial personality problems versus people who never had RPs (596 individuals). Additionally, participants with multiple or persistent RPs were more likely to receive any attention-deficit/hyperactivity disorder diagnoses, including the hyperactive/impulsive subtype. In young adulthood, there were no associations seen between multiple or persistent RPs and IQ scores.
"The results indicate long-lasting associations between multiple or persistent RPs and behavioral problems," the authors write. "Thus, screening for early RPs could help to identify children who are at risk for later behavioral problems."
Related Posts
Vision Troubles Could Raise Midlife Depression Risk for Women
WEDNESDAY, Oct. 27 2021 (HealthDay News) -- Midlife vision problems could...
Por qué las escaleras podrían ser un mayor peligro para las mujeres jóvenes
VIERNES, 28 de julio de 2023 (HealthDay News) -- Cuando se trata de caerse por...
CDC Backs Full Approval of Moderna COVID Vaccine
FRIDAY, Feb. 4, 2022 (HealthDay News) -- The U.S. Centers for Disease Control...
La metformina, un medicamento para la diabetes, podría evitar la COVID grave
MIÉRCOLES, 23 de noviembre de 2022 (HealthDay News) -- Un medicamento para la...